Erstellt von ogangurel

Blog

An Unfolding Tragedy Balancing Act Between Innovation and Access
Autor
A Pharmaceutical Addiction
Autor
Chief Partnership Officer An Idea Whose Time Has Come
Autor
A Time To Make Friends More Partnerships in Biotech Med Tech
Autor
Bleeding Stents Is The Drug-Eluting Stent Era Over
Autor
Biotech Med Tech Business Models Investors Patients Deserve Better
Autor
Bio Electromagnetic Therapies Science Fiction or Reality
Autor
Diabetes Looking Past Blood Sugar
Autor
Convergent Medical Technology Part I - What Is It
Autor
Avandia The Drug Safety Debate and How To Get A Nobel Prize
Autor
Convergent Medical Technology Part II Why Is It Important
Autor
FDA Panel Votes To Retain Avandia On The Market DrugWonks Celebrate Prince Hal Rails Against Falstaff
Autor
Expanding Health Coverage To The Uninsured How To Pay For It - The Health Impact Tax
Autor
Drug-Eluting Stent Market 5 Billion Turning On A Dime
Autor
Boston Scientific Medtronic Settle Some Defibrillator Suits Is The Device Safety Storm Over
Autor
Counterdetailing A Cure For A Pharmaceutical Addiction
Autor
Drug Device Safety Debate To Yield Big Changes Grow More Controversial
Autor
Financial Incentives Can Drive New Pharmaceutical & Medical Technology Adoption What Are The Implications
Autor
FDA Reform Redux On Business Models, Regulatory Reform and Safety
Autor
Drug-Eluting Stents Part One Triple Storm Catching Industry Attention
Autor
FDA Report On Avandia Implications and A Critique of The Critique
Autor
Drug-Eluting Stents Part Two Triple Storm Catching Industry Attention
Autor
Medical Diplomacy A Brief Outline
Autor
Innovations Galore Spawning From 2008 Medical Design Excellence Awards MDEA
Autor
How Doctors Think Implications For Life Science Business Finance
Autor
KKR Buys First Data On Private Equity, Pipelines, Development
Autor
Intellectual Property Does It Matter
Autor
FDA-Approved Artificial Heart From Abiomed A Whimper Not A Bang
Autor
FDA Tortoise Hare or Something Else
Autor
On Innovation Part II Fostering Innovation
Autor
Medicare Part D What The Benefit Means For Medical Technology
Autor
Lance Armstrong and The Future of Cancer Care
Autor
Medical Design Excellence Awards Offer Decisive Glimpse Into Future of Health Care
Autor
Patent Reform Act of 2007 Innovation Implications and The American Inventor
Autor
Personalized Medicine and Technology Convergence Decisive Trends
Autor

Blog

An Unfolding Tragedy Balancing Act Between Innovation and Access

A Pharmaceutical Addiction

Chief Partnership Officer An Idea Whose Time Has Come

A Time To Make Friends More Partnerships in Biotech Med Tech

Bleeding Stents Is The Drug-Eluting Stent Era Over

Biotech Med Tech Business Models Investors Patients Deserve Better

Bio Electromagnetic Therapies Science Fiction or Reality

Diabetes Looking Past Blood Sugar

Convergent Medical Technology Part I - What Is It

Avandia The Drug Safety Debate and How To Get A Nobel Prize

Convergent Medical Technology Part II Why Is It Important

FDA Panel Votes To Retain Avandia On The Market DrugWonks Celebrate Prince Hal Rails Against Falstaff

Expanding Health Coverage To The Uninsured How To Pay For It - The Health Impact Tax

Drug-Eluting Stent Market 5 Billion Turning On A Dime

Boston Scientific Medtronic Settle Some Defibrillator Suits Is The Device Safety Storm Over

Counterdetailing A Cure For A Pharmaceutical Addiction

Drug Device Safety Debate To Yield Big Changes Grow More Controversial

Financial Incentives Can Drive New Pharmaceutical & Medical Technology Adoption What Are The Implications

FDA Reform Redux On Business Models, Regulatory Reform and Safety

Drug-Eluting Stents Part One Triple Storm Catching Industry Attention

FDA Report On Avandia Implications and A Critique of The Critique

Drug-Eluting Stents Part Two Triple Storm Catching Industry Attention

Medical Diplomacy A Brief Outline

Innovations Galore Spawning From 2008 Medical Design Excellence Awards MDEA

How Doctors Think Implications For Life Science Business Finance

KKR Buys First Data On Private Equity, Pipelines, Development

Intellectual Property Does It Matter

FDA-Approved Artificial Heart From Abiomed A Whimper Not A Bang

FDA Tortoise Hare or Something Else

On Innovation Part II Fostering Innovation

Medicare Part D What The Benefit Means For Medical Technology

Lance Armstrong and The Future of Cancer Care

Medical Design Excellence Awards Offer Decisive Glimpse Into Future of Health Care

Patent Reform Act of 2007 Innovation Implications and The American Inventor

Personalized Medicine and Technology Convergence Decisive Trends